This protocol is judged by an institutional review board, an impartial team that reviews any clinical trials involving human beings. If a research consists of a Program I drug, when the board approves the protocol as ethical, the researchers need to apply for an investigational new drug (IND) selection from the FDA.If this is The 1st time everyone